Across multiple solid tumors, glucagon-like peptide 1 receptor agonist (GLP-1 RA) initiation after cancer diagnosis is ...

Adding encorafenib (Braftovi) and cetuximab (Erbitux) to FOLFIRI chemotherapy significantly improved progression-free ...

Phase 3 results showed the treatment nearly doubled survival for patients with previously treated metastatic pancreatic ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...

The metastatic HER2-positive breast cancer market outlook continues to be promising, supported by ongoing innovation, expanding therapeutic indications, lifecycle management initiatives, and ...

Breast cancer can go away for a while and then show up again. It can also spread to different areas of your body when it comes back. Sometimes, breast cancer returns and spreads to the pleura, the ...

A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

A new experimental drug for metastatic pancreatic cancer nearly doubled overall survival in a ...